Convincing evidence now supports a probable preventive role for physical activity in postmenopausal breast cancer. The mechanisms by which long-term physical activity affect …
K Subik, JF Lee, L Baxter, T Strzepek… - Breast cancer: basic …, 2010 - journals.sagepub.com
The molecular classification for breast carcinomas has been used in clinical studies with a simple surrogate panel of immunohistochemistry (IHC) markers. The objective of this current …
P Farmer, H Bonnefoi, V Becette… - Breast Cancer …, 2005 - Springer
S2 cancer in the general population remains unclear. Furthermore, the methodology of ATM mutation detection is still laborious and costly. Because the ATM protein kinase …
LC Collins, KS Cole, JD Marotti, R Hu, SJ Schnitt… - Modern Pathology, 2011 - Elsevier
Previous studies have demonstrated that androgen receptor is expressed in many breast cancers, but its expression in relation to the various breast cancer subtypes as defined by …
LA Niemeier, DJ Dabbs, S Beriwal, JM Striebel… - Modern Pathology, 2010 - Elsevier
Androgens exert growth inhibitory effects on estrogen receptor and progesterone receptor- negative breast cancer cell lines that show androgen receptor expression. These laboratory …
S Park, J Koo, HS Park, JH Kim, SY Choi, JH Lee… - Annals of oncology, 2010 - Elsevier
Background To investigate the clinicopathological significance of androgen receptor (AR) expression in primary breast cancers. Patients and methods We evaluated AR using …
S Park, JS Koo, MS Kim, HS Park, JS Lee, SI Kim… - Annals of …, 2011 - Elsevier
Background The objective of the study was to evaluate the implications of androgen receptor (AR) in breast cancers. Patients and methods We investigated immunohistochemical AR …
S Loibl, BM Müller, G von Minckwitz… - Breast cancer research …, 2011 - Springer
The androgen receptor (AR) has been shown to be of potential prognostic importance in retrospective cohorts. We evaluated immunohistochemical AR expression on a tissue …
M Rampurwala, KB Wisinski… - Clinical advances in …, 2016 - ncbi.nlm.nih.gov
Triple-negative breast cancer (TNBC) is an aggressive disease with outcomes inferior to those of other breast cancer subtypes. No targeted therapies are currently approved for …